|
Dr. Mukund Chorghade is President of Chorghade Enterprises and Chief Scientific Officer, THINQ Pharma, where he provides consultations to pharmaceutical companies on collaborations with academic, government and industrial laboratories. He advises technology based companies on process re-engineering and project management of technology transfer; establishes strategic partnerships and conducts cGLP/cGMP training and implementation in academic and industrial laboratories. He oversees projects in chemical route selection, process development, chemical manufacturing and formulation of bulk actives to finished dosage forms.
Dr. Chorghade earned his B. Sc. and M. Sc. degrees from the University of Poona in India and a Ph. D. in organic chemistry at Georgetown University in Washington, D. C., in 1982. He completed postdoctoral appointments at the University of Virginia and Harvard University, visiting scientist appointments at University of British Columbia, Vancouver, Canada, College de France / Universite’ Louis Pasteur, Harvard University Cambridge University, Caltech and MIT. He has directed research groups at Dow Chemicals, Abbott Laboratories, CytoMed and Genzyme. He was the recipient of three “Scientist of the Year Awards” and had the honor of being a featured speaker in several national and international symposia. He is active in ACS, is NESACS Chair and is on the International Activities Committee.
|
|
